Phosphate excess, a hallmark of CKD, triggers this transformation via MAPK and NF-κB activation, as demonstrated in rat models where zinc supplementation inhibited calcification by enhancing TNFAIP3-mediated NF-κB suppression (67). Here, NFKB1 is linked to chronic kidney disease.